How to Capture Data to Improve Specialty Pharmacy Operations

Nov 21, 2016

Lauren Santye, Assistant Editor

John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how specialty stakeholders can accurately encapsulate the high volume of data they produce to improve operations.

John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how specialty stakeholders can accurately encapsulate the high volume of data they produce to improve operations.

Related Videos

Biosimilars | Image credit: lexiconimages - stock.adobe.com

Medical care team | Image credit: Iryna - stock.adobe.com

Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com

Medical science laboratory | Image credit: alphaspirit - stock.adobe.com

Gastroenterologist using digital x-ray of human intestine holographic scan projection 3D rendering | Image Credit: sdecoret - stock.adobe.com

Pharmacist managing inventory | Image credit: StratfordProductions - stock.adobe.com

Nursing giving infusion to senior patient | Image credit: Studio Romantic - stock.adobe.com

Cirrhosis illustration | Image credit: Rasi - stock.adobe.com

Related Content

Key Metrics That Support the Integrated Specialty Pharmacy Model

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

The Latest in the Role of Pharmacogenomics in Mental Health Treatment

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Medication Acquisition Programs Can Improve Access to Treatment

Biosimilar Infliximab-dyyb Demonstrates Same Effectiveness as Remicade in Pediatric Patients

Key Metrics That Support the Integrated Specialty Pharmacy Model

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

The Latest in the Role of Pharmacogenomics in Mental Health Treatment

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Medication Acquisition Programs Can Improve Access to Treatment

Biosimilar Infliximab-dyyb Demonstrates Same Effectiveness as Remicade in Pediatric Patients

Key Metrics That Support the Integrated Specialty Pharmacy Model

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

The Latest in the Role of Pharmacogenomics in Mental Health Treatment

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Medication Acquisition Programs Can Improve Access to Treatment

Biosimilar Infliximab-dyyb Demonstrates Same Effectiveness as Remicade in Pediatric Patients

Related Content

Pharmacist holding medicine box and capsule pack in pharmacy drugstore. Credit: I Viewfinder - stock.adobe.com

Key Metrics That Support the Integrated Specialty Pharmacy Model

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

Image Credit: Adobe Stock - motortion

The Latest in the Role of Pharmacogenomics in Mental Health Treatment

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Credit: Prostock-studio - stock.adobe.com.

Medication Acquisition Programs Can Improve Access to Treatment

Credit: TarikVision - stock.adobe.com

Biosimilar Infliximab-dyyb Demonstrates Same Effectiveness as Remicade in Pediatric Patients

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.